Lantern Pharma
LTRN
LTRN
34 hedge funds and large institutions have $9.75M invested in Lantern Pharma in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.31% less ownership
Funds ownership: 10.63% → 10.32% (-0.31%)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
34
Holding in Top 10
–
Calls
$1.19M
Puts
$207K
Top Buyers
| 1 | +$227K | |
| 2 | +$219K | |
| 3 | +$193K | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$167K |
| 5 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$132K |
Top Sellers
| 1 | -$257K | |
| 2 | -$252K | |
| 3 | -$132K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$106K |
| 5 |
MWM
Meridian Wealth Management
Lexington,
Kentucky
|
-$84.1K |